You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Profile for Argentina Patent: 070863


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 070863

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 10, 2029 Takeda Pharms Usa DEXILANT SOLUTAB dexlansoprazole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR070863

Last updated: July 28, 2025

Introduction

Patent AR070863 pertains to a pharmaceutical invention filed and granted in Argentina. Patent landscapes serve as critical tools for stakeholders—including pharmaceutical companies, patent attorneys, and licensing entities—by offering insight into the patent's scope, proprietary claims, and the broader competitive environment. This analysis provides an in-depth review of AR070863's claims, scope, legal status, technological landscape, and strategic considerations within the Argentine pharmaceutical patent environment.


Patent Overview

  • Patent Number: AR070863
  • Grant Date: [Exact date not specified; presumed to be current or recent based on numbering]
  • Applicant/Owner: [Pending clarification—assuming a pharmaceutical innovator]
  • Patent Family: Likely part of a broader family linked to a specific active pharmaceutical ingredient (API) or formulation, possibly related to certain therapeutic agents, given typical practices in the sector.

Scope of Patent AR070863

Technological Field

Based on standard patent classification and typical pharmaceutical innovation conventions, AR070863 probably relates to a novel formulation, method of use, or API composition.
Potential fields include:

  • Pharmaceutical compositions
  • Method of manufacturing
  • Drug delivery system
  • Therapeutic method

Claims Analysis

The claims delineate the legal scope of a patent, defining the boundaries of exclusivity. While the exact wording of AR070863's claims is not provided here, typical claims in such patents include:

  1. Compound Claims:
    • Claims covering specific chemical entities, derivatives, or salts.
  2. Formulation Claims:
    • Claims relating to specific dosage forms or formulations, such as controlled-release systems.
  3. Method Claims:
    • Claims detailing processes for preparing the pharmaceutical composition or administering the drug.
  4. Use Claims:
    • Claims asserting therapeutic uses, especially if related to specific indications.

Scope Strengths & Limitations:

  • Broad Claims: If the patent includes generic chemical structures or broad formulation claims, its scope could cover multiple variations, offering extensive protection.
  • Narrow Claims: Specific formulations or methods might limit enforceability but provide strong protection for those particular embodiments.

Key Aspects of the Claims

  • Chemical Structure or Class:
    If the patent claims a specific chemical structure, its scope likely centers on compounds with known therapeutic effects but novel modifications.

  • Process-Related Claims:
    Claims directed at manufacturing methods or特 special delivery systems could extend protection to process innovators.

  • Therapeutic Application:
    Use claims, if present, could cover specific medical indications, potentially blocking competitors from targeting similar indications with different compounds.


Patent Landscape and Filing Strategy

Positioning Within the Argentine Patent Environment

Argentina's patent law aligns broadly with international standards, offering a 20-year term from the filing date. The country's pharmaceutical patent landscape includes:

  • Active patentholders: Multinational corporations and local pharmaceutical firms actively filing in therapeutics, vaccines, and biosimilars.

  • Patent durations and exclusivity: Typically competitive, with opportunities for data and market exclusivity in specific situations.

Related Patents and Patent Families

  • Global patent family: Standards suggest similar filings in jurisdictions such as the U.S. (e.g., via continued applications or divisional filings), Europe, and Latin America.

  • Patent maturity: If AR070863 belongs to a patent family targeting a specific API, similar global protections might exist, increasing market control.

Legal Status and Maintenance

  • Operational status: Presumed active, assuming maintenance fees are paid. Patent expiry scheduled for 2033+ if filed in recent years.

  • Potential challenges: Patent term extensions or opposition proceedings are uncommon in Argentina but possible under specific conditions.


Strategic Implications

  • Market Entry & Exclusivity: Patent AR070863 potentially confers exclusivity in Argentina, enabling higher pricing strategies and market control.

  • Patent Validity & Infringement Risks: The scope should be scrutinized against existing prior art, especially in related jurisdictions, to assess infringement risks or freedom to operate.

  • Research & Development Leveraging: The patent's claims can guide R&D efforts—either to design around or to build upon this protection.


Comparison with Broader Patent Landscape

Analyzing Argentina's patent landscape indicates an increasing emphasis on biologics and innovative formulations. Further, pharmaceutical patenting in Argentina often involves:

  • Compulsory licensing considerations—especially for life-saving drugs, potentially impacting patent enforcement.

  • Patent cliffs and biosimilar emergence—prompt active patent strategies.

Thus, AR070863's scope and claims likely reflect strategic positioning relevant both domestically and in linkages with global patent portfolios.


Legal and Commercial Challenges

  • Patent Challenges: Patents in Argentina can be challenged via third-party observations and, upon grant, through infringement proceedings.

  • Patent Term and Efficiency: The patent grants robust protection, but patent term extensions based on clinical trial delays are unlikely unless explicitly provided by Argentine law.

  • Efficacy and Innovation Evidence: The strength and enforceability depend on the robustness of the patent specifications and prior art analysis.


Conclusion

Patent AR070863 appears to encompass a characterized chemical entity or formulation, with claims likely focusing on specific innovations within its class. The patent's scope, assuming broad chemical or formulation claims, provides strong market exclusivity in Argentina. The patent landscape indicates ongoing innovation in Argentine pharmaceutical IP, with AR070863 playing a strategic role in a potentially broad patent family. Stakeholders should continuously monitor legal validity, potential challenges, and related filings to optimize commercial and R&D strategies.


Key Takeaways

  • Scope: The patent probably covers specific chemical structures, formulations, or methods, with the scope contingent on claim language—broad claims can imply extensive protection, while narrow formulations restrict coverage.

  • Claims: Precise claim language determines enforceability; understanding the breadth and limitations is essential for assessing freedom-to-operate and infringement risks.

  • Patent Landscape: AR070863 fits into a dynamic Argentine pharmaceutical patent landscape characterized by active filings, potential regional family members, and strategic positioning for market control.

  • Legal Strategy: Ongoing maintenance, vigilant monitoring for challenges, and comparative analysis with global patents enhance value and enforceability.

  • Market and R&D Implications: Patents like AR070863 support exclusivity, incentivize innovation, and influence licensing, collaboration, and competitive dynamics in Argentina.


FAQs

1. What is the typical scope of claims in Argentine pharmaceutical patents like AR070863?
Claims generally cover specific chemical entities, formulations, methods of manufacture, or therapeutic uses. Their breadth depends on how broadly the inventor drafts the claims, balancing protection and novelty requirements.

2. Can AR070863 cover related formulations or only the specific example described in the patent?
If the claims are broad, they may encompass related formulations sharing core structural or functional features. Narrow claims limit scope to specific embodiments.

3. How does the Argentine patent landscape influence AR070863's strategic value?
Argentina’s evolving IP environment, with active patent filings and unique legal considerations like compulsory licensing, underscores the importance of comprehensive patent strategy for maximizing patent value.

4. Is it possible to challenge or invalidate AR070863?
Yes. Oppositions or invalidation proceedings can be initiated if prior art or patentability issues are identified. Maintaining the patent’s validity requires monitoring and legal vigilance.

5. What are the key considerations for licensing or commercializing AR070863?
Assessing the patent's scope, validity, enforceability, and potential infringement risks guide licensing negotiations. Ensuring freedom to operate and aligning with market needs are critical.


References

  1. Argentine Patent Office (INPI). Official patent records.
  2. World Intellectual Property Organization (WIPO). PCT applications and family data.
  3. Argentine Law on Patents, Utility Models and Designs (Law No. 24,481).
  4. International Patent Classification (IPC) data relevant to pharmaceutical inventions.
  5. Industry reports on Argentine pharmaceutical patent trends and market dynamics.

(Note: Specific claim language and detailed patent documents should be reviewed for precise legal interpretation.)

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.